Alastair K. Denniston

On the 10th of September, the Commission published its recommendations to government, 44 recommendations covering how we should approach regulation of AI in healthcare.

The commission was chaired by Professor Alastair Denniston, an ophthalmologist, academic and professor of regulatory science.

And I'm delighted to have him with me on the podcast today.

We're going to unpack what the commission found, what its recommendations mean, and perhaps most importantly, what they could mean for the future of AI regulation and innovation in the UK.

It's not the government's, strictly speaking.

Chaired by Professor Alistair Denniston, and it brought together a number of leading lights and luminaries from the healthcare world, technology world, and the legal world.

And indeed, its findings were informed by a call for evidence process, which involved, amongst other things, a UK-wide research and engagement programme, engagement with healthcare professionals, industry and patients.

It had a... pretty wide remit.

On Wednesday, I went to the Science Media Centre to hear from the chief executive of the MHRA, Lawrence Tallon, alongside several other members of the commission.

Professor Alistair Denniston, who is chair of the commission and an NHS consultant, began by explaining how the commission's 44 recommendations fit into three key areas.

You'll see that there are three core principles within the report and the individual recommendations sit under each of these principles.

The first is that we need a risk proportionate approach.